4//SEC Filing
Weiss Patrick 4
Accession 0001214659-21-013286
CIK 0001581280other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:35 PM ET
Size
12.7 KB
Accession
0001214659-21-013286
Insider Transaction Report
Form 4
Weiss Patrick
VP of Operations
Transactions
- Exercise/Conversion
Common Stock
2021-12-14$25.02/sh+827$20,692→ 50,289 total - Sale
Common Stock
2021-12-14$84.00/sh−2,801$235,284→ 47,488 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-12-14−827→ 19,859 totalExercise: $25.02Exp: 2029-12-09→ Common Stock (827 underlying) - Exercise/Conversion
Common Stock
2021-12-14$26.66/sh+1,974$52,627→ 49,462 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-12-14−1,974→ 47,376 totalExercise: $26.66Exp: 2028-11-18→ Common Stock (1,974 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 11, 2021.
- [F2]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F3]25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001755793
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:35 PM ET
- Size
- 12.7 KB